New England Research Institutes And ProMedica CRC, Inc. Form Strategic Alliance to Support Phase I-IV Clinical Research Studies
Published: May 27, 2009
WATERTOWN, Mass. & BOSTON--(BUSINESS WIRE)--New England Research Institutes, Inc. (NERI), a global contract research organization (CRO) focused on Phase II-IV clinical trials and ProMedica Clinical Research Center (CRC), Inc., a dedicated Phase I firm, today announced their strategic alliance. As a result of this new working relationship, both companies can now provide pharmaceutical, medical device, biomaterial and biotechnology clients with seamless and comprehensive clinical research solutions for Phase I-IV studies in a variety of therapeutic areas.